HR 9598 · 118th Congress 2023–2025, ended

Office of National Drug Control Policy Reauthorization Act of 2024

Latest action · Dec 9, 2024 Received in the Senate and Read twice and referred to the Committee on the Judiciary.

Progress

Where this bill reached, and when. A stage with no date was not reached; one that failed a vote and later carried shows the date it carried.

  1. IntroducedSep 16, 2024
  2. Passed HouseDec 5, 2024
  3. Passed SenateNot reached
  4. To the PresidentNot reached
  5. Became lawNot reached

Summary

Office of National Drug Control Policy Reauthorization Act of 2024

This bill reauthorizes through FY2031 the Office of National Drug Control Policy and related grants, programs, and initiatives such as 

  • the High Intensity Drug Trafficking Areas program, 
  • the Drug-Free Communities program, 
  • the Drug Court Training and Technical Assistance program, and
  • the National Community Anti-Drug Coalition Institute.

Recorded votes 1

Newest first. Open one to see how every member voted.

Roll callQuestionResultDate
House 485On Motion to Suspend the Rules and Pass, as AmendedPassed399–1Dec 5, 2024

Yea 399

Nay 1

Cosponsors 5

Members who signed on, in the order they did. All signed on Sep 16, 2024.

SeatCosponsorSigned on
D-MDJamie RaskinOriginalSep 16, 2024
R-PRJenniffer González-ColónOriginalSep 16, 2024
D-NYJerrold NadlerOriginalSep 16, 2024
R-CAJohn S. DuarteOriginalSep 16, 2024
D-VIStacey E. PlaskettOriginalSep 16, 2024

Committees 4

Where it was sent and what each committee and subcommittee did with it, in order.

ChamberCommitteeWhat it did
HouseOversight and Government Reform Committee
Referred Sep 16, 2024Markup Sep 18, 2024
HouseJudiciary Committee
Referred Sep 16, 2024
HouseEnergy and Commerce Committee
Referred Sep 16, 2024
SenateJudiciary Committee
Referred Dec 9, 2024

Actions 12

Everything that happened, newest first.

  1. Dec 9, 2024Received in the Senate and Read twice and referred to the Committee on the Judiciary.
  2. Dec 5, 2024Considered as unfinished business. (consideration: CR H6395-6396)
  3. Dec 5, 2024Passed/agreed to in House: On motion to suspend the rules and pass the bill, as amended Agreed to by the Yeas and Nays: (2/3 required): 399 - 1 (Roll no. 485). (text: 12/4/2024 CR H6319-6322)
  4. Dec 5, 2024Motion to reconsider laid on the table Agreed to without objection.
  5. Dec 4, 2024Mr. Comer moved to suspend the rules and pass the bill, as amended.

In the Congressional Record 3

Days the Record’s own index lists this bill, newest first, with the pages and the members it names. Pages starting H are the House, S the Senate, E Extensions of Remarks.

WhereIn the RecordMembersDate
HouseDebate and remarks H7334Stacey E. Plaskett D-VIDec 18, 2024
HouseRecorded votes H6396reauthorize—Dec 5, 2024
HouseDebate and remarks H6319–H6324Text printed H6319–H6322James Comer R-KY, Jamie Raskin D-MD, Jenniffer González-Colón R-PR, John S. Duarte R-CADec 4, 2024

Research

What has been written about this bill: committee reports, cost estimates, the sponsor’s authority statement, printed hearings and the Congressional Research Service’s work.

Constitutional authority

Congress has the power to enact this legislation pursuant to the following: Article I, Section 8, clause 3 of the Constitution, in that the legislation regulates forms of commerce specified in that clause; and, Article I, Section 8, clause 18 of the Constitution, in that the legislation ``is necessary and proper for carrying into Execution the foregoing Powers'' and ``other Powers vested by this Constitution in the Government of the United States, or in any Department or Officer thereof,'' including the powers of the President specified in Article II of the Constitution. The single subject of this legislation is: To reauthorize the Office of National Drug Control Policy.

The sponsor’s statement, as printed in the Congressional Record, vol. 170, no. 143, September 16, 2024, page H5239.

Titles 4

Every title it has carried, official and short, at each stage.

Official Title as Introduced
To amend the Office of National Drug Control Policy Reauthorization Act to reauthorize such Office, and for other purposes.
Short Title(s) as Introduced
Office of National Drug Control Policy Reauthorization Act of 2024
Short Title(s) as Passed House
Office of National Drug Control Policy Reauthorization Act of 2024
Short Titles from RFS (Referred to Senate) bill text
Office of National Drug Control Policy Reauthorization Act of 2024

Subjects

Assigned by the Library of Congress. Policy area: Crime and Law Enforcement.

Text 3

Each version as it was printed, newest first.

  1. Dec 9, 2024Referred in Senate
  2. Dec 5, 2024Engrossed in House
  3. Sep 16, 2024Introduced in House

Support LegiList

This page is free, carries no paywall, and is built and maintained by one person. If the record here is useful to you, a few dollars keeps it going.

Processed by Stripe in a separate window. LegiList never sees card details.

Everything here is as published by Congress: the summary is the Congressional Research Service's, the action wording is the clerks', and the subjects are the Library of Congress's. How far it got is read from the actions themselves, taking the most recent one of each kind, so a bill that failed a vote and later passed is shown as having passed. Records come from this bill on Congress.gov and govinfo.gov; cost estimates are the Congressional Budget Office's, and the hearings are the printed hearings GovInfo publishes, which can appear months after the hearing.